We spoke to Andrew Doig, professor of biochemistry at the University of Manchester, to find out more about the evolving landscape of Alzheimer's treatments.

Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision ...

The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president’s Florida golf courses is due to appear in court ...

Their stories come as the county is undergoing a public reckoning over child welfare policies ...